Cargando…

Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine

OBJECTIVE: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program. METHODS: Sixty-five stool samples were collected from children younger than 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Maina, Meshach Maunta, Faneye, Adedayo Omotayo, Motayo, Babatunde Olanrewaju, Nseabasi-Maina, Ntung, Adeniji, Adekunle Johnson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511342/
https://www.ncbi.nlm.nih.gov/pubmed/36138570
http://dx.doi.org/10.1177/03000605221121956
_version_ 1784797631789137920
author Maina, Meshach Maunta
Faneye, Adedayo Omotayo
Motayo, Babatunde Olanrewaju
Nseabasi-Maina, Ntung
Adeniji, Adekunle Johnson
author_facet Maina, Meshach Maunta
Faneye, Adedayo Omotayo
Motayo, Babatunde Olanrewaju
Nseabasi-Maina, Ntung
Adeniji, Adekunle Johnson
author_sort Maina, Meshach Maunta
collection PubMed
description OBJECTIVE: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program. METHODS: Sixty-five stool samples were collected from children younger than 5 years with clinically diagnosed diarrhea and screened for the presence of rotavirus and norovirus using RT-PCR. Rotavirus-positive samples were further analyzed to determine the G and P genotypes using semi-nested multiplex PCR. RESULTS: The rates of rotavirus and norovirus positivity were 30.8% and 10.8%, respectively, whereas the rate of rotavirus and norovirus mixed infection was 4.6%. G1 was the predominant VP7 genotype, followed by G2, G9, and G1G2G9, whereas the predominant VP4 genotype was P[4], followed by P[6], P[8], and P[9]. The mixed P types P[4]P[8] and P[4]P[6] were also detected. G1P[4] was the most common VP4 and VP7 combination, followed by G2P[4], G1[P6], G1P[8], G2P[6], G2P[9], G9P[6], G2G9P[4], G2P[4]P[6], G1P[4]P[8], G2G9P[8], G1G2G9P[8], and G1[non-typable] P[non-typable], which were detected in at least 5% of the samples. Four samples had a combination of non-typable G and P types. CONCLUSIONS: It is essential to monitor the circulation of virus strains prior to and during the implementation of the immunization program.
format Online
Article
Text
id pubmed-9511342
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-95113422022-09-27 Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine Maina, Meshach Maunta Faneye, Adedayo Omotayo Motayo, Babatunde Olanrewaju Nseabasi-Maina, Ntung Adeniji, Adekunle Johnson J Int Med Res Prospective Clinical Research Report OBJECTIVE: This cross-sectional study investigated the circulating strains of rotavirus and screened for noravirus in Ibadan, Nigeria as the country introduces the rotavirus vaccine into its national immunization program. METHODS: Sixty-five stool samples were collected from children younger than 5 years with clinically diagnosed diarrhea and screened for the presence of rotavirus and norovirus using RT-PCR. Rotavirus-positive samples were further analyzed to determine the G and P genotypes using semi-nested multiplex PCR. RESULTS: The rates of rotavirus and norovirus positivity were 30.8% and 10.8%, respectively, whereas the rate of rotavirus and norovirus mixed infection was 4.6%. G1 was the predominant VP7 genotype, followed by G2, G9, and G1G2G9, whereas the predominant VP4 genotype was P[4], followed by P[6], P[8], and P[9]. The mixed P types P[4]P[8] and P[4]P[6] were also detected. G1P[4] was the most common VP4 and VP7 combination, followed by G2P[4], G1[P6], G1P[8], G2P[6], G2P[9], G9P[6], G2G9P[4], G2P[4]P[6], G1P[4]P[8], G2G9P[8], G1G2G9P[8], and G1[non-typable] P[non-typable], which were detected in at least 5% of the samples. Four samples had a combination of non-typable G and P types. CONCLUSIONS: It is essential to monitor the circulation of virus strains prior to and during the implementation of the immunization program. SAGE Publications 2022-09-22 /pmc/articles/PMC9511342/ /pubmed/36138570 http://dx.doi.org/10.1177/03000605221121956 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Prospective Clinical Research Report
Maina, Meshach Maunta
Faneye, Adedayo Omotayo
Motayo, Babatunde Olanrewaju
Nseabasi-Maina, Ntung
Adeniji, Adekunle Johnson
Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
title Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
title_full Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
title_fullStr Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
title_full_unstemmed Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
title_short Human rotavirus VP4 and VP7 genetic diversity and detection of GII norovirus in Ibadan as Nigeria introduces rotavirus vaccine
title_sort human rotavirus vp4 and vp7 genetic diversity and detection of gii norovirus in ibadan as nigeria introduces rotavirus vaccine
topic Prospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511342/
https://www.ncbi.nlm.nih.gov/pubmed/36138570
http://dx.doi.org/10.1177/03000605221121956
work_keys_str_mv AT mainameshachmaunta humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine
AT faneyeadedayoomotayo humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine
AT motayobabatundeolanrewaju humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine
AT nseabasimainantung humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine
AT adenijiadekunlejohnson humanrotavirusvp4andvp7geneticdiversityanddetectionofgiinorovirusinibadanasnigeriaintroducesrotavirusvaccine